Garnet Equity Capital Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Garnet Equity Capital Holdings, Inc.

  • $286 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$680.49 - $826.97 $1.36 Million - $1.65 Million
2,000 New
2,000 $1.64 Million
Q3 2021

Oct 19, 2021
SELL
$574.03 - $680.96 $4.59 Million - $5.45 Million
-8,000 Closed
0 $0
Q2 2020

Aug 04, 2020
BUY
$493.32 - $643.92 $3.95 Million - $5.15 Million
8,000 New
8,000 $4.99 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Garnet Equity Capital Holdings, Inc. Portfolio

Follow Garnet Equity Capital Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garnet Equity Capital Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Garnet Equity Capital Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email